BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2003
View Archived Issues
Enrollment complete in phase III trial of Vivitrex in alcohol dependence
Read More
GOT trial studies methods for achieving glycemic control in diabetes
Read More
AstraZeneca seeks approval for Nexium in NSAID-associated upper GI symptoms
Read More
Zymar approved for bacterial conjunctivitis
Read More
Regeneron announces positive preliminary phase III results with Axokine
Read More
Dual CCR3 modulators/H1 antagonists and their use reported by AstraZeneca
Read More
Novel antibacterial/antiinflammatory indolicidin-derived peptides
Read More
Leo Pharma presents novel TNF-alpha and IL-1beta production inhibitors
Read More
New GABA-A modulators for anxiety and convulsions under study at Merck
Read More
Alpha7 nicotinic acetylcholine receptor agonists presented by Pharmacia
Read More
Novel NPY antagonists in Banyu development pipeline
Read More
Yissum researchers prepare and test new DNA-damaging platinum complexes
Read More
Imidazole cell adhesion inhibitors discovered by Sankyo team
Read More
Oral zebularine reactivates silenced genes, inhibits DNA methylation
Read More
Takeda plans two trials of Actos in heart disease
Read More
NCX-1020 enters clinical development
Read More
Ganite sNDA filing completed
Read More
Pennsaid approved in Canada
Read More
Initiation of first of two expanded phase II trials of GVAX lung cancer vaccine
Read More
Chimeric peptides show high potency in CHF in preclinical studies
Read More
Oxford BioMedica cleared to begin phase II trial of TroVax in colorectal cancer
Read More
Phase III program to assess fondaparinux in acute coronary syndromes
Read More
Statistically significant improvement in FSAD in Alista at-home study
Read More
Characterization of new CDK1/CDK2 inhibitor
Read More
FAUC-312 identified as potent and selective partial agonist at D4 receptors
Read More
Orally active triazole inhibitors of TNF-alpha production designed by P&G
Read More
Glutamate antagonists with selectivity for the ionotropic GluR5 receptor under study at NeuroSearch
Read More